GTHX   $7.16  0.14% Market Closed

G1 Therapeutics Inc
Total Cash 60.73M
totalCashPerShare 1.151
EBITDA -37.39M
Total Debt 47.96M
quickRatio 1.974
currentRatio 2.478
Total Revenue 58.20M
debtToEquity 195.039
Revenue/Share 1.118
ROA -0.19203
ROE -1.09009
grossProfits
freeCashflow -19.83M
operatingCashflow -37.54M
earningsGrowth
revenueGrowth -0.61
grossMargins 0.89442
ebitdaMargins -0.64246005
operatingMargins -0.21365
profitMargins -0.76931
enterpriseValue 364.46M
forwardPE 143.0
floatShares 39.15M
sharesOutstanding 52.76M
sharesShort 3.41M
sharesShortPriorMonth 5.77M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.11%
heldPercentInstitutions 0.54%
Short Ratio help_outline 1.01%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 0.467
Price To Book help_outline 15.31
earningsQuarterlyGrowth
netIncomeToCommon -44.77M
trailingEps -0.86%
forwardEps 0.05%
enterpriseToEbitda -9.75
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.1 3Q 2024
institutionsCount 125
lastUpdated Sept. 16, 2024, 3:15 p.m.